Updates are available Correction dated 2025-01-30
Click to view Correction: https://doi.org/10.1007/s12020-025-04162-6
-
Authors
Iughetti, Lorenzo https://orcid.org/0000-0003-0370-7872
Antoniazzi, Franco https://orcid.org/0000-0003-1405-1792
Giavoli, Claudia https://orcid.org/0000-0002-6787-1543
Bellone, Simonetta https://orcid.org/0000-0001-8521-497X
Aversa, Tommaso https://orcid.org/0000-0002-1754-6822
Guazzarotti, Laura https://orcid.org/0000-0002-5648-0109
Street, Maria Elisabeth https://orcid.org/0000-0001-8427-8971
Miraglia del Giudice, Emanuele https://orcid.org/0000-0002-9410-5393
Persani, Luca https://orcid.org/0000-0003-2068-9581
Pozzobon, Gabriella https://orcid.org/0000-0002-2618-2506
Ragusa, Letizia https://orcid.org/0000-0001-7285-9365
Stagi, Stefano https://orcid.org/0000-0002-2259-4685
Tornese, Gianluca https://orcid.org/0000-0002-4395-3915
Zecchino, Clara
Mameli, Chiara https://orcid.org/0000-0002-6768-3411
Zecchi, Emiliano
Fedeli, Paolo
Zabransky, Markus
Lucaccioni, Laura https://orcid.org/0000-0003-0288-8990
Zucchini, Stefano https://orcid.org/0000-0003-1184-7170
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 29 October 2024
First Online: 29 November 2024
Change Date: 14 January 2025
Change Type: Update
Change Details: The original online version of this article was revised due to a retrospective Open Access cancellation.
Change Date: 30 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12020-025-04162-6
Compliance with ethical standards
:
: Lorenzo Iughetti has received fees for participation on advisory boards from Sandoz. Franco Antoniazzi has received research funding from Merck Serono and Sandoz, and fees for participation on advisory boards from BioMarin. Tommaso Aversa has consulted for Pfizer and Sandoz. Luca Persani has received fees for participation on advisory boards from Sandoz. Gabriella Pozzobon has received consulting fees and for participation on advisory boards from Sandoz, Merck Serono and Novo Nordisk. Emiliano Zecchi, Paolo Fedeli and Markus Zabransky are part of Sandoz Company Organization. Claudia Giavoli, Simonetta Bellone, Laura Guazzarotti, Maria Elisabeth Street, Emanuele Miraglia del Giudice, Stefano Stagi, Gianluca Tornese, Chiara Mameli, Laura Lucaccioni, Letizia Ragusa, Clara Zecchino, and Stefano Zucchini have no relevant financial or non-financial interests to disclose.
: The study was reviewed and approved by each study site’s Independent Ethics Committee/Institutional Review Board.
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committees, with the 1964 Helsinki Declaration and its later amendments, and with the ethical principles outlined in the Oviedo Human Rights Convention.
: All patients (or their parents/legal guardians) provided written informed consent before study inclusion.
